| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/13/2005 | CN1638776A Substituted 3-aryl-5-aryl-[1, 2, 4]-oxadiazoles and analogs |
| 07/13/2005 | CN1638766A Use of substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase |
| 07/13/2005 | CN1638761A Azetidine derivatives as CCR-3 receptor antagonists |
| 07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636977A 1, 3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210269C Preparation of 4-trioalkylbromobenzene derivatives |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916834 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
| 07/12/2005 | US6916814 Methods of treating cytokine mediated diseases |
| 07/12/2005 | US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 07/12/2005 | US6916802 Synthase inhibitors for lowering glycosphingolipid levels; anticancer agents; for treatment of Gaucher's disease |
| 07/12/2005 | US6916667 Metal chelate containing compositions for use in chemiluminescent assays |
| 07/12/2005 | CA2094335C 4,1-benzoxazepin derivatives and their use |
| 07/07/2005 | WO2005061491A2 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors |
| 07/07/2005 | WO2005061490A1 Hydroxypyrimidinone derivative having hiv integrase inhibitory activity |
| 07/07/2005 | WO2005061489A1 Heterocyclic derivatives as gpcr receptor agonists |
| 07/07/2005 | WO2005061487A1 Hiv protease inhibiting compounds |
| 07/07/2005 | WO2005061484A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061468A1 Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| 07/07/2005 | WO2005061467A2 Piperazine derivatives as bradykinin antagonists |
| 07/07/2005 | WO2005061466A1 Novel phenylalanine derivative |
| 07/07/2005 | WO2005061463A1 Pyrazole derivatives as protein kinase modulators |
| 07/07/2005 | WO2005061457A1 Organic compounds |
| 07/07/2005 | WO2005061455A1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 07/07/2005 | WO2005060970A1 Pyrimidines with tie2 (tek) activity |
| 07/07/2005 | WO2005060969A1 Pyrimidines with tie2 (tek) activity |
| 07/07/2005 | WO2005060959A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 07/07/2005 | WO2005060958A1 (5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes |
| 07/07/2005 | WO2005060749A1 Substituted arylpyrazoles as parasiticidal agents |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005042521A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 07/07/2005 | WO2005035495A3 Fibrinogen receptor antagonists and their use |
| 07/07/2005 | US20050148770 Synthetic methodology for the reductive alkylation at the C-3 position of indoles |
| 07/07/2005 | US20050148649 Substituted arylpyrazoles |
| 07/07/2005 | US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative |
| 07/07/2005 | US20050148640 For therapy and prophylaxis of heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, destructive bone disorders such as osteoporosis, proliferative disorders, infectious diseases, immunologically-mediated diseases |
| 07/07/2005 | US20050148638 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 07/07/2005 | US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment |
| 07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/07/2005 | US20050148608 Chymase enzyme inhibitors for drugs in vascular systems using sulfonylurea derivatives |
| 07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
| 07/07/2005 | US20050148601 Neurokinin-3 receptor modulators: diaryl imidazole derivatives |
| 07/07/2005 | US20050148586 Quinoxalinones |
| 07/07/2005 | US20050148581 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance |
| 07/07/2005 | US20050148574 Imidazole compositions useful as inhibitors of protein kinases |
| 07/07/2005 | US20050148573 Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 07/07/2005 | CA2550843A1 Novel phenylalanine derivatives |
| 07/07/2005 | CA2550643A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 07/07/2005 | CA2549955A1 Heterocyclic derivatives as gpcr receptor agonists |
| 07/07/2005 | CA2549308A1 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2548374A1 Pyrazole derivatives as protein kinase modulators |
| 07/07/2005 | CA2529314A1 Piperazine derivatives and methods of use |
| 07/06/2005 | EP1550657A1 Amine compounds and use thereof |
| 07/06/2005 | EP1549713A1 Synergistic uv absorber combination |
| 07/06/2005 | EP1549643A2 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine |
| 07/06/2005 | EP1549642A1 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| 07/06/2005 | EP1549641A1 Antimicrobial 3.1.0 bicyclic oxazolidinone derivatives |
| 07/06/2005 | EP1549640A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/06/2005 | EP1549639A1 Sulphonamide derivatives as antipsychotic agents |
| 07/06/2005 | EP1549635A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549624A2 Inhibitors of fatty acid amide hydrolase |
| 07/06/2005 | EP1549620A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
| 07/06/2005 | EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity |
| 07/06/2005 | EP1549316A1 INHIBITORS OF TFG&bgr; |
| 07/06/2005 | EP1549304A1 Heterocyclic amides and their use in treating thromboembolic diseases and tumors |
| 07/06/2005 | EP1315720B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/06/2005 | EP1212320B1 Phenylpiperazines as serotonin reuptake inhibitors |
| 07/06/2005 | CN1636154A Di-substituted iminoheterocyclic compounds |
| 07/06/2005 | CN1636006A Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 07/06/2005 | CN1635891A Tetrahydroquinoline analogues as muscarinic agonists |
| 07/06/2005 | CN1209016C Fungicides |
| 07/05/2005 | US6914058 1-(p-(thiomorpholino)phenyl)-1,2,3-triazole derivatives |
| 07/05/2005 | CA2309485C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 07/05/2005 | CA2183972C Oxazolidinone derivatives and pharmaceutical compositions containing them |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2072541C Heterocyclic compounds, their production and use |
| 06/30/2005 | WO2005059107A2 Chemokine receptor binding compounds |
| 06/30/2005 | WO2005058888A2 Oxazolidinone-quinolone hybrid antibiotics |
| 06/30/2005 | WO2005058886A1 Novel oxazolidinone derivatives |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058871A1 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 06/30/2005 | WO2005058868A1 N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
| 06/30/2005 | WO2005058848A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| 06/30/2005 | WO2005058845A2 Novel glucagon antagonists/inverse agonists |
| 06/30/2005 | WO2005058837A1 Benzazepine derivatives as histamine h3 antagonists |
| 06/30/2005 | WO2005058836A1 Insecticidal spiroindane derivatives |
| 06/30/2005 | WO2005058834A2 Quinolines useful in treating cardiovascular disease |
| 06/30/2005 | WO2005058832A1 Diacylhydrazine derivatives |